GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
3.140
-0.260 (-7.64%)
Jul 2, 2025, 3:16 PM - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $9.89 million as of July 2, 2025. Its market cap has increased by 52.80% in one year.
Market Cap
9.89M
Enterprise Value
7.46M
1-Year Change
52.80%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $9.89M, a decrease of -98.95%. That is a compound annual growth rate of -10.33%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |